Benign prostatic hyperplasia (BPH) significantly affects quality of life in aging men. When medical therapies fail to relieve lower urinary tract symptoms (LUTS), surgical intervention becomes necessary.
Among modern surgical options, Holmium Laser Enucleation of the Prostate (HoLEP) stands out as an established standard. For international residents and patients in the Incheon and Gyeonggi metropolitan areas, understanding the clinical indications and recovery process is essential before choosing a surgical pathway.
What Is HoLEP Surgery and How Does It Work?
HoLEP is an advanced, minimally invasive transurethral procedure. It uses a high-powered holmium laser to separate the obstructing adenoma from the outer prostate capsule.
The procedure follows two distinct physiological steps:
- Enucleation: The surgeon peels away the enlarged transitional zone tissue along natural anatomical planes, mimicking open surgery without skin incisions.
- Morcellation: The enucleated tissue is pushed into the bladder and mechanical morcellation grinds it into tiny fragments for removal and histological analysis.
Because the holmium laser coagulates blood vessels during resection, HoLEP significantly reduces intraoperative blood loss compared to traditional electrocautery methods.
Clinical Indications: When Is HoLEP Recommended?
Urologists do not recommend surgery for every patient with urinary symptoms. Objective diagnostic criteria determine surgical candidacy.
Primary Indications
- Moderate-to-severe symptoms with an International Prostate Symptom Score (IPSS) above 19.
- Prostates larger than 60 grams, where conventional transurethral resection of the prostate (TURP) carries higher complication rates.
- Recurrent urinary tract infections or persistent urinary retention requiring catheterization.
- Presence of bladder stones secondary to chronic outlet obstruction.
- Elevated post-void residual (PVR) volume exceeding 150 to 200 mL.
When NOT to Choose HoLEP
- Prostate volume under 30 grams, where minimally invasive options like Rezūm or UroLift may suffice.
- Known neurogenic bladder or detrusor underactivity without mechanical obstruction.
- Patients unable to tolerate anesthesia due to severe cardiopulmonary compromise.
- Active, untreated urinary tract infections or acute prostatitis.
Surgical Options for BPH: A Structured Comparison
Evaluating BPH treatments requires balancing tissue removal efficiency against recovery time and sexual function preservation.
- HoLEP (Holmium Laser Enucleation)
- Prostate Size: Suitable for any size (30g to over 200g).
- Tissue Removal: Complete anatomical enucleation.
- Catheter Duration: Typically 1 to 2 days.
- Ejaculatory Function: High rate of retrograde ejaculation (70% to 80%).
Long-term Retreatment Rate: Very low (under 2% at 5–10 years).
Standard TURP (Transurethral Resection)
- Prostate Size: Optimal for 30g to 80g.
- Tissue Removal: Progressive loop resection.
- Catheter Duration: 2 to 4 days.
- Ejaculatory Function: High rate of retrograde ejaculation (60% to 75%).
Long-term Retreatment Rate: Moderate (5% to 10% within 5 years).
Aquablation (Robotic Waterjet Resection)
- Prostate Size: Suitable for 30g to 150g.
- Tissue Removal: Heat-free robotic waterjet ablation.
- Catheter Duration: 1 to 2 days.
- Ejaculatory Function: Higher preservation rates (ejaculatory hood sparing).
Long-term Retreatment Rate: Low to moderate based on recent 5-year data.
Minimally Invasive Therapies (UroLift / Rezūm)
- Prostate Size: Best for 30g to 80g without severe median lobe obstruction.
- Tissue Removal: Mechanical compression or thermal vapor ablation.
- Catheter Duration: 0 to 3 days.
- Ejaculatory Function: Preserved in over 90% of cases.
- Long-term Retreatment Rate: Higher re-intervention rate (8% to 15% at 5 years).
Clinical Reality Check: Side Effects and Recovery Timeline
Patients must maintain realistic expectations regarding postoperative recovery. Complete tissue healing inside the prostatic urethra takes several weeks.
Normal Post-Operative Symptoms
- Mild dysuria and burning sensation during urination for 1 to 3 weeks.
- Transient stress urinary incontinence or urinary urgency, which resolves in over 95% of patients within 1 to 3 months through pelvic floor conditioning.
- Intermittent light pink discoloration in the urine, especially after bowel movements or brisk walking.
Red Flag Symptoms Requiring Immediate Medical Attention
- Inability to urinate (acute urinary retention).
- Heavy, dark red hematuria with thick blood clots.
- Persistent body temperature exceeding 38.0°C (100.4°F).
- Severe pelvic or perineal pain unresponsive to prescribed oral analgesia.
Navigating Urological Surgery in Incheon
Selecting a specialized center in Incheon requires verifying diagnostic infrastructure, surgeon volume, and emergency contingency protocols.
High-volume centers in Incheon, such as Goldman Urology’s Incheon branch in Guwol-dong, utilize high-capacity 120H Holmium laser systems alongside high-resolution Olympus endoscopic platforms. Furthermore, advanced diagnostic integration—such as S-Fusion™ targeted biopsy and rapid AI-assisted uro-diagnostic solutions—allows clinicians to rule out concurrent prostate malignancies accurately before laser enucleation.
Specialized outpatient protocols in Korea frequently employ targeted caudal pelvic anesthesia. This approach avoids the spinal headache and prolonged immobility associated with traditional neuroaxial blocks, enabling rapid post-surgical ambulation and same-day recovery workflows.
Expert Perspective
Dr. Changgi Lee from Goldman Urology stated, “Selecting the right surgical intervention for an enlarged prostate must always be guided by anatomical precision and individual lifestyle goals. While HoLEP remains the gold standard for durable, long-term obstruction relief, especially in significantly enlarged glands, the key to minimizing complications lies in comprehensive pre-operative evaluation and surgical volume. At our centers across Seoul and Incheon, we leverage over two decades of clinical data and multimodal surgical platforms to ensure that every patient receives a safe, evidence-based, and rapid path back to optimal urinary health.”
To learn more about clinical prostate care protocols and diagnostic evaluations, visit: http://gold-man.com/en
Medical Disclaimer: This content is intended for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Patients experiencing lower urinary tract symptoms should undergo formal clinical evaluation by a board-certified urologist.